Extranodal extension is a strong prognosticator in HPV‐positive oropharyngeal squamous cell carcinoma
- 11 May 2019
- journal article
- conference paper
- Published by Wiley in The Laryngoscope
- Vol. 130 (4) , 939-945
Abstract
Objective: To comprehensively examine the prognostic significance of extranodal extension (ENE) in human papillomavirus–positive oropharyngeal squamous cell carcinoma (HPV‐positive OPSCC).Methods: Retrospective cohort of cases diagnosed with HPV‐positive OPSCC from 2010 to 2015 in the National Cancer Database. Inclusion of all OPSCC HPV‐positive cases with appropriate International Classification of Diseases‐0‐3 codes that received surgery with a neck dissection. Univariate and multivariable analyses were conducted. Hazard ratios (HR) for the independent effects of ENE and N stage on overall survival were estimated by Cox proportional hazards regression.Results: Cases that were ENE‐negative had the highest 5‐year survival (92.6%; 95% confidence interval [CI]: 90.5%–94.7%). ENE‐positive cases had the lowest 5‐year survival (84.0%; 95% CI: 80.7%−87.4%). After adjusting for confounding variables, ENE‐positivity was associated with almost twice the hazard of death (HR = 1.90; 95% CI: 1.35–2.67) compared to ENE‐negative cases. Nodal (N) category 1, ENE‐positive status was associated with an increased risk of death (HR = 1.88; 95% CI: 1.26–2.80) compared with N1, ENE‐negative status. Compared to N1/ENE‐negative cases, N2/ENE‐positive cases had the poorest survival (HR: 2.93; 95% CI: 1.94–4.43). Both microscopic and macroscopic ENE were associated with worse outcomes compared to node‐positive/ENE‐negative status.Conclusion: The implementation of the American Joint Committee on Cancer 8th edition staging system provides a much‐improved framework to develop and discuss treatment plans for HPV‐positive OPSCC. We feel that careful consideration should be given to the importance of ENE in patients with HPV‐positive OPSCC.Level of Evidence: 4Laryngoscope, 130:939–945, 2020Keywords
This publication has 26 references indexed in Scilit:
- Extracapsular spread and adjuvant therapy in human papillomavirus‐related, p16‐positive oropharyngeal carcinomaCancer, 2011
- Observer variation in the histopathologic assessment of extranodal tumor spread in lymph node metastases in the neckHead & Neck, 2011
- Human papillomavirus and oropharynx cancer: Biology, detection and clinical implicationsThe Laryngoscope, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteriGynecologic Oncology, 2008
- Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)Head & Neck, 2005
- Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2004
- Interest of Pelvic and Paraaortic Lymphadenectomy in Patients with Stage IB and II Cervical CarcinomaGynecologic Oncology, 1999
- Prognostic factors of neck node metastasisClinical Otolaryngology, 1982
- The Extracapsular Spread of Tumors in Cervical Node MetastasisJAMA Otolaryngology–Head & Neck Surgery, 1981